Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ppg Industries (PPG) Asset Writedowns and Impairment (2018 - 2023)

Ppg Industries (PPG) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with $13.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Asset Writedowns and Impairment rose 1200.0% to $13.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $160.0 million, a 81.82% increase, with the full-year FY2025 number at $24.0 million, down 83.56% from a year prior.
  • Asset Writedowns and Impairment was $13.0 million for Q4 2023 at Ppg Industries, down from $147.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $147.0 million in Q1 2022 to a low of -$60.0 million in Q2 2022.
  • A 4-year average of $51.7 million and a median of $21.0 million in 2021 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 1200.0% in 2023; the steepest drop was 0.0% in 2023.
  • Ppg Industries' Asset Writedowns and Impairment stood at $93.0 million in 2020, then crashed by 77.42% to $21.0 million in 2021, then plummeted by 95.24% to $1.0 million in 2022, then soared by 1200.0% to $13.0 million in 2023.
  • Per Business Quant, the three most recent readings for PPG's Asset Writedowns and Impairment are $13.0 million (Q4 2023), $147.0 million (Q1 2023), and $1.0 million (Q4 2022).